中国学术期刊网络出版总库入编期刊
CNKI中文期刊全文数据库全文收录期刊
中国核心期刊(遴选)数据库全文收录期刊
万方数据——数字化期刊群收录期刊
中文科技期刊数据库全文收录期刊

主管:陕西省卫生健康委员会
主办:西安心身医学研究所
   西安交通大学第一附属医院
国际标准刊号:ISSN2096—1413
国内统一刊号:CN61—1503/R

盐酸羟考酮控释片联合普瑞巴林在癌性神经病理性疼痛治疗中的效果

李安民,王登

(商洛市第二人民医院,陕西 商洛,726000)

浏览次数:529次 下载次数:425次

摘要:

目的 研究盐酸羟考酮控释片联合普瑞巴林在癌性神经病理性疼痛治疗中的效果。方法 收集本院2010年2月至2016年2月收治的100例神经病理性疼痛患者,按照随机数字表法分为观察组和对照组,每组50例,患者入院后均采取必要的心理干预与机体调养,随后给予两组患者盐酸羟考酮控释片,与此同时观察组患者联合使用普瑞巴林,观察两组患者的镇痛 效果、生命质量及睡眠质量。结果 随着治疗时间的延长,两组患者的疼痛、生命质量及睡眠质量评分均呈降低趋势;治疗15 d后,两组患者的疼痛、生命质量及睡眠质量评分均低于治疗后8 d 和治疗前;治疗后8 d,两组患者的疼痛、生命质量及睡眠质量评分低于治疗前(P<0.05);观察组患者治疗后8、15 d的的疼痛、生命质量及睡眠质量评分均低于对照组(P<0.05)。结论 采取盐酸羟考酮控释片联合普瑞巴林联合用药的治疗效果要优于单一盐酸羟考酮控释片,值得临床上推荐或参考。

关键词:盐酸羟考酮控释片;普瑞巴林;疼痛治疗

中图分类号:R614文献标志码:A文章编号:2096-1413(2017)30-0009-02

    Application effect of oxycodone hydrochloride controlled release tablets combined with pregabalin on malignant neuropathic pain
    LI An-min, WANG Deng
    (the Second People``s Hospital of Shangluo City, Shangluo 726000, China)

    ABSTRACT: Objective To study the effect of oxycodone hydrochloride controlled release tablets combined with pregabalin on malignant neuropathic pain. Methods From February 2010 to February 2016, 100 patients with malignant neuropathic pain in our hospital were randomly divided into observation group and control group, with 50 cases in each group. All the patients taken the necessary psychological intervention and body care. Then the two groups took oxycodone hydrochloride controlled-release tablets; at the same time, the observation group received pregabalin as the combined therapy. Results With the prolongation of treatment time, the pain, quality of life and sleep quality score of the two groups showed a decreasing trend; at 15 d after treatment, the pain, quality of life and sleep quality scores of the two groups were lower than those before treatment and at 8 d after treatment; at 8 d after treatment, the pain, quality of life and sleep quality scores of the two groups were lower than those before treatment (P<0.05); the pain, quality of life and sleep quality scores of the observation group 8, 15 d after treatment were lower than those of the control group (P<0.05). Conclusion Oxycodone hydrochloride controlled release tablets combined with pregabalin on malignant neuropathic pain has better treatment effect than single oxycodone hydrochloride controlled release tablets, which is worthy of clinical reference or recommendation.

    KEYWORDS: oxycodone hydrochloride controlled release tablets; pregabalin; pain treatment

    参考文献:
    [1] 王朝杰,周云.普瑞巴林联合盐酸羟考酮控释片治疗中重度癌性疼痛临床观察[J].中华实用诊断与治疗杂志,2013,27(8):801-802.
    [2] 王新林,彭军瑞,王湘辉.盐酸羟考酮控释片联合加巴喷丁治疗晚期癌症神经病理性疼痛疗效分析[J].现代肿瘤医学,2012,20(9):1930-1932.
    [3] 杨娅娟,李惠萍,苏丹,等.癌症患者自我感受负担与社会支持及生命质量的相关性研究[J].中国全科医学,2014,17(1):94-97.
    [4] 曾黎明,李君.普瑞巴林联合盐酸羟考酮控释片治疗带状疱疹后神经痛的效果分析[J].山西医药杂志,2015,12(24):2905-2907.
    [5] 李登峰,颜明.富氢液联合羟考酮控释片对癌性神经病理性疼痛的临床疗效观察[J].中国医师杂志,2016,18(9):1329-1331,1335.
    [6] 章必成,章志怀,王俊,等.普瑞巴林联合盐酸羟考酮治疗癌性神经病理痛33 例[J].医药导报,2015,34(3):325-328.
    [7] 成宪江,刘维帅,王昆.神经妥乐平联合羟考酮控释片治疗癌性神 经病理性疼痛的疗效观察[J].中国肿瘤临床,2015,42(11):546-549.

上一篇N/A

下一篇全植入式输液港在肿瘤化疗中的应用